GNTI-122 was engineered through dual HDR–based editing to stably express endogenous FOXP3 at the FOXP3 locus and an islet antigen–specific TCR at the TRAC locus in bulk CD4+ cells from healthy donors and from donors with T1D. The gene discussed is FOXP3; the disease is type 1 diabetes mellitus.